CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	1 Months Ended	3 Months Ended			7 Months Ended	9 Months Ended	10 Months Ended
	Mar. 31, 2021	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income	$ (11,768)	$ 2,668,049	$ 1,671,654	$ 6,049,580	$ 5,994,892	$ 6,865,260
Adjustments to reconcile net income to net cash used in operating activities:
Realized gain on investments held in Trust Account		(410,818)		0	0	(521,431)
Unrealized gain on investments held in Trust Account		(487,146)		(3,059)	(3,059)	(678,622)
Expensed offering costs		0		762,517	762,517	0
Change in fair value of warrant liabilities					(7,153,945)	(6,472,616)
Changes in operating assets and liabilities:
Prepaid expenses					(561,937)	212,774
Accounts payable and accrued expenses					110,149	(100,561)
Franchise tax payable					116,393	(119,265)
Net cash used in operating activities					(734,990)	(814,461)
Cash Flows from Investing Activities:
Proceeds from Sale of Debt Securities, Available-for-Sale					0	365,098,000
Payments to Acquire Debt Securities, Available-for-Sale					0	(365,098,000)
Investment of cash into Trust Account					(182,219,150)	0
Net cash used in investing activities					(182,219,150)	0
Cash Flows from Financing Activities:
Proceeds from promissory note - related party					300,000	0
Repayment of promissory note - related party					(300,000)	0
Proceeds from initial public offering, net of underwriting fees					176,806,700	0
Proceeds from sale of Private Placement Warrants					8,012,451	0
Payment of deferred offering costs					(764,193)	0
Proceeds from sale of Class B common stock to Sponsor					25,000	0
Net cash provided by financing activities					184,079,958	0
Net Change in Cash					1,125,818	(814,461)
Cash - Beginning of period	$ 0		$ 842,059		0	842,059	$ 0
Cash - End of period		$ 27,598		$ 1,125,818	1,125,818	27,598	$ 842,059
Non-cash investing and financing activities
Deferred underwriting fee payable					6,314,525	0
Excess of the fair value of Founder Shares sold over the purchase price					4,714,400	0
Forfeiture of Class B common stock					52	0
Accretion of Class A common stock subject to redemption to redemption value					25,015,823	0
Subsequent accretion of Class A common stock subject to redemption to redemption amount as of September 30, 2022					0	1,200,053
Deferred offering costs included in accrued offering costs					$ 395,252	$ 0